Outcomes of Treat-and-Extend versus Pro Re Nata Anti-VEGF Injections for Myopic Macular Neovascularization in Patients in the United States

被引：0
|
作者：
Swaminathan, Shreya [1 ]
Mahmoudzadeh, Raziyeh [2 ]
Wakabayashi, Taku [2 ]
Bowers, Mallory Elva [1 ]
Abishek, Robert [2 ]
Salabati, Mirataollah [2 ]
Hsu, Jason [2 ]
Dunn, James P. [2 ]
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA
[2] Wills Eye Hosp & Res Inst, Philadelphia, PA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] REAL WORLD OUTCOMES OF TREAT-AND-EXTEND AND PRO RE NATA DOSING STRATEGIES VERSUS MONTHLY DOSING FOR NEOVASCULAR AGE RELATED MACULAR DEGENERATION USING RANIBIZUMAB: A LITERATURE REVIEW AND ECONOMIC ANALYSIS
    Rufai, S. R.
    Hamami, H.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (02) : E83 - E83
  • [22] Influence of posterior vitreous detachment on extendability of treat-and-extend anti-VEGF therapy in neovascular age-related macular degeneration
    Klimscha, Sophie
    Coulibaly, Leon
    Sadeghipour, Amir
    Gerendas, Bianca S.
    Waldstein, Sebastian M.
    Schmidt-Erfurth, Ursula
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [23] Comparison of Outcomes in Patients with Neovascular Age-Related Macular Degeneration Managed with Anti-VEGF on Conventional Treat-and-Extend vs. Trial-Stop Regimens
    Weng, Christina Y.
    Lin, Weijie Violet
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [24] Treat-and-extend dosing of intravitreal anti-VEGF agents in neovascular age-related macular degeneration: a meta-analysis
    Nichani, Prem A. H.
    Popovic, Marko M.
    Dhoot, Arjan S.
    Pathak, Ananya
    Muni, Rajeev H.
    Kertes, Peter J.
    EYE, 2023, 37 (14) : 2855 - 2863
  • [25] Treat-and-extend dosing of intravitreal anti-VEGF agents in neovascular age-related macular degeneration: a meta-analysis
    Prem A. H. Nichani
    Marko M. Popovic
    Arjan S. Dhoot
    Ananya Pathak
    Rajeev H. Muni
    Peter J. Kertes
    Eye, 2023, 37 : 2855 - 2863
  • [26] Changes in metamorphopsia after the treat-and-extend regimen of anti-VEGF therapy for macular edema associated with branch retinal vein occlusion
    Mori, Kenichiro
    Ishikawa, Keijiro
    Wada, Iori
    Kubo, Yuki
    Kobayashi, Yoshiyuki
    Nakama, Takahito
    Haruta, Masatoshi
    Akiyama, Masato
    Nakao, Shintaro
    Yoshida, Shigeo
    Sonoda, Koh-Hei
    PLOS ONE, 2020, 15 (10):
  • [27] The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen
    Takamura, Yoshihiro
    Kida, Teruyo
    Noma, Hidetaka
    Inoue, Makoto
    Yoshida, Shigeo
    Nagaoka, Taiji
    Noda, Kousuke
    Yamada, Yutaka
    Morioka, Masakazu
    Gozawa, Makoto
    Matsumura, Takehiro
    Inatani, Masaru
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (24)
  • [28] Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
    Wecker, Thomas
    Grundel, Bastian
    Reichl, Sabine
    Stech, Milena
    Lange, Clemens
    Agostini, Hansjuergen
    Boehringer, Daniel
    Stahl, Andreas
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
    Thomas Wecker
    Bastian Grundel
    Sabine Reichl
    Milena Stech
    Clemens Lange
    Hansjürgen Agostini
    Daniel Böhringer
    Andreas Stahl
    Scientific Reports, 9
  • [30] Pro re nata anti-VEGF treatment results for neovascular age-related macular degeneration in routine clinical treatment: comparison of single with triple injections
    Wintergerst, M. W. M.
    Larsen, P. P.
    Heimes, B.
    Pauleikhoff, D.
    Holz, F. G.
    Finger, R. P.
    OPHTHALMOLOGE, 2019, 116 (05): : 441 - 446
12345